BioAgilytix appoints Nathan Speicher as Chief Financial Officer

The Latest News from BioAgilytix

30 June, 2022

BioAgilytix appoints Nathan Speicher as Chief Financial Officer

Durham, NC, June 30, 2022 – BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research organization focused on supporting pharmaceutical and biotech partners in all phases of drug development, has appointed…

Read More

23 June, 2022

BioAgilytix appoints Christie Knittel Mabry as new Chief People Officer

Durham, NC, June 23, 2022 – BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research organization focused on supporting pharmaceutical and biotech partners in all phases of drug development, has…

Read More

9 May, 2022

BioAgilytix appoints top healthcare executive David King to its Board of Directors

Durham, NC, May 9, 2022 – BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research organization focused on supporting pharmaceutical and biotech partners in all phases of drug development, has…

Read More

4 May, 2022

BioAgilytix Appoints Two New Scientific Officers

Durham, NC, May 4, 2022 – BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research organization focused on supporting pharmaceutical and biotech partners in all phases of drug development, has appointed two…

Read More

12 January, 2022

Serving the growing biotechnology community

Read More

21 December, 2021

Cinven Completes Majority Investment in BioAgilytix

Investment will Power Further Expansion of Core Business and Drive Future Growth of the Company  December 21, 2021—Durham, NC, USA and London, UK—BioAgilytix, a leading global contract research organization (CRO),…

Read More

24 November, 2021

BioAgilytix Secures Significant New Investment from Global Investor Cinven to Fuel Continued Long-Term Growth

Investment Will Provide BioAgilytix with Additional Resources to Invest in Core Business and Drive GrowthNovember 17, 2021—Durham, NC, USA, Brussels, Belgium and London, UK—BioAgilytix, a leading global contract research organization…

Read More

13 October, 2021

BioAgilytix Closes Acquisition of Australia-based 360biolabs®

Following final government approval, 360biolabs, a BioAgilytix company, adds world-class virology & immunology expertise and LC/MS/MS small molecule capabilities to the company, enabling support of bioanalytical services across all geographies…

Read More

4 October, 2021

BioAgilytix Announces New Partnership With CTI

Alliance to strengthen both companies’ ability to provide a seamless, full-service bioanalytical client experience across the full spectrum of lifecycle developmentDurham, NC, October 4, 2021 – BioAgilytix Labs, LLC (BioAgilytix), a leading…

Read More